Name | Title | Contact Details |
---|
NeuroVision is developing a noninvasive, quick, and inexpensive retinalimaging test for the early detection and diagnosis of Alzheimer`s disease.
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to the Kansas economy in several ways. The company surpasses $1 billion in annual claims payments to health care providers and members and contributes more than $140 million a year to the economy through payroll and taxes. The company's headquarters are located in Topeka, KS. Nearly 1,400 employees work in the company's various office locations in Topeka. In addition, about 110 employees work in offices in Dodge City, Garden City, Hays, Hutchinson, Independence, Lawrence, Manhattan, Pittsburg, Salina and Wichita. BCBSKS is a member of the Blue Cross Blue Shield Association headquartered in Chicago. There are 36 Blue Cross and Blue Shield Plans throughout the United States. Each Plan is separate and independent but all Plans cooperate with other Blue Cross and Blue Shield Plans in the exchange of ideas, processing of claims and providing inter-plan services to customers.
Iora Health is transforming health care, starting with primary care.
SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.
Pullman Regional Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Pullman, WA. To find more information about Pullman Regional Hospital, please visit www.pullmanregional.org